Karius
San Francisco, US · Founded 2014 · 216 employees on LinkedIn · 5 known investors
Karius is a company that provides microbial cell-free DNA (mcfDNA) metagenomic sequencing services for research and clinical applications. The company runs an Investigator-Initiated Studies grants program to support independent research on diagnostic testing outcomes, health economics, and fundamental science related to its sequencing technology.
Founders & leadership
AF

Alec FordinChief Executive Officer
Investors · 5
Competitors · 1
by search overlapCompanies competing with Karius for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Karius do?
- Karius is a company that provides microbial cell-free DNA (mcfDNA) metagenomic sequencing services for research and clinical applications. The company runs an Investigator-Initiated Studies grants program to support independent research on diagnostic testing outcomes, health economics, and fundamental science related to its sequencing technology.
- Who are Karius's investors?
- Karius's investors include 5AM Ventures, DCVC (Data Collective), Khosla Ventures, Lightspeed Venture Partners, SoftBank Vision Fund.
- Where is Karius headquartered?
- Karius is headquartered in San Francisco, US.


